BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2007
View Archived Issues
Huya licenses ex-China rights to chidamide
Read More
GSK reviews 2006 progress, anticipates 2007 milestones
Read More
Exelixis updates EXEL-2819 profile
Read More
IRBM presents second-generation class I HDAC inhibitors at recent congress
Read More
GPI-1046 inhibits HIV-associated sensory neuropathy in vivo
Read More
NYVAC-C HIV vaccine assessed with and without DNA-C in healthy volunteers
Read More
T-cell increases seen in HIV-infected patients given recombinant interleukin-7
Read More
New treatment options for neurological disorders disclosed in recent patent literature
Read More
Novel factor Xa inhibitor described at GSK
Read More
Phase Ib/II data on single agent ADH-1 presented
Read More
Dyax and Glenmark to cooperate on discovery of therapeutic antibodies
Read More
NGX-267 studied in multiple-dose phase I trial
Read More
BioLineRx in-licenses novel drug delivery system
Read More
First human microdosing trial completes for I-3D compound
Read More
Novel treatment strategy for glaucoma and ocular hypertension claimed by Allergan
Read More
Novel therapeutic strategies for metabolic disorders described in recent patents
Read More
ObeCure begins phase II study for OBE-101 to prevent Zyprexa weight gain
Read More
Cell Therapeutics seeks SPA for pixantrone trial in indolent NHL
Read More
Enzo studies gene therapy for HIV-1 in phase I/II trial
Read More
IND filing for pivotal study of improved octreotide formulation
Read More
Allegra Oral Suspension now available for children
Read More
GTC grants expanded license to PharmAthene in support of Protexia
Read More
Virax grants Transgene access to Co-X-Gene technology
Read More
SPA agreement for phase III EOquin trials in noninvasive bladder cancer
Read More
Amitiza begins U.S. postmarking studies, Japanese phase I study
Read More
MEM-354 begins phase IIa study for Alzheimer's disease
Read More
CYT003-QbG10 significantly improves allergy symptoms in hay fever patients
Read More
Tyrima safe and well tolerated in phase I trial
Read More